SINOVAC BIOTECH LTD
SVA · Pharmaceutical Preparations
Latest available SEC filing: 20-F ·
Latest disclosures
-
Latest financial period: Q4 2025
Financial facts · Filed
-
Form 20-F
SEC filing · Filed
-
Form 20-F
SEC filing · Filed
-
Li Jiaqiang: Form 3
Insider disclosure · Filed · Report period 17 Apr 2026
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- SVA · P8696W104 - Common Shares, par value US$0.001 per share
Company details and SEC sources
CIK 0001084201 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- SVA on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- No. 39 Shangdi Xi Road, Haidian District, Beijing, 100085
- Incorporated in
- Antigua and Barbuda
- Fiscal year end
- 31 December
- Former names on EDGAR
- NET FORCE SYSTEMS INC (to 13 Jan 2004)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields